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Background: Currently, comparative genomic hybridisation
array (array CGH) is the method of choice for studying
genome wide DNA copy number changes. To date, either
amplified representations of bacterial artificial chromosomes
(BACs)/phage artificial chromosomes (PACs) or cDNAs have
been spotted as probes. The production of BAC/PAC and
cDNA arrays is time consuming and expensive.
Aim: To evaluate the use of spotted 60 mer oligonucleotides
(oligos) for array CGH.
Methods: The hybridisation of tumour cell lines with known
chromosomal aberrations on to either BAC or oligoarrrays
that are mapped to the human genome.
Results: Oligo CGH was able to detect amplifications with
high accuracy and greater spatial resolution than other
currently used array CGH platforms. In addition, single copy
number changes could be detected with a resolution
comparable to conventional CGH.
Conclusions: Oligos are easy to handle and flexible, because
they can be designed for any part of the genome without the
need for laborious amplification procedures. The full genome
array, containing around 30 000 oligos of all genes in the
human genome, will represent a big step forward in the
analysis of chromosomal copy number changes. Finally,
oligoarray CGH can easily be used for any organism with a
fully sequenced genome.
A
rray comparative genomic hybridisation (array CGH)
has been used successfully for the detection of genomic
imbalances in human and mouse tumours.1–6 As chro-
mosomal representations, approximately 2500 bacterial arti-
ficial chromosome (BAC) and phage artificial chromosome
(PAC) clones have been amplified and spotted for genome
wide CGH arrays, yielding a resolution of 1–1.5 Mb,7 in addi-
tion to cDNAs,8 which encompass a maximum of 13 824
genes and yield an average resolution of 267 kb.9 Although
spatial resolution using cDNAs is currently higher, the num-
ber of cDNAs is finite and their sensitivity is lower. This
reduced sensitivity of cDNAs is partly the result of cross
hybridisation. Oligonucleotides (oligos) can theoretically cir-
cumvent the problems encountered with cDNAs. In addition,
oligo-libraries are cheaper, easier to work with, and faster
than cDNAs or BAC/PAC clones, because no DNA isolation or
PCR amplification steps are necessary. The in silico design can
control for the hybridisation temperature and specificity and
there is no limit to the spatial resolution. Finally, oligos can be
designed for any organism with a sequenced genome.
MATERIALS AND METHODS
BAC array preparation
DNA from the 1 Mb resolution Sanger BAC set (http://
www.ensembl.org/Homo_sapiens/cytoview), the OncoBac set
(http://informa.bio.caltech.edu/Bac_onc.html), and in house
clones of interest, supplemented with clones from the
Children’s Hospital Oakland Research Institute (CHORI),
amounting to a total of 4202 clones with known chromoso-
mal positions, was isolated according to the CHORI protocol
(http://bacpac.chori.org/dnaprep.htm). Amplification of the
DNA was done by ligation mediated polymerase chain
reaction (PCR) according to Snijders et al,7 and PCR clones
were purified using Montage PCRH m96 filter plates
(Millipore BV, Amsterdam, the Netherlands). Clones were
spotted at a concentration of 10 mg/ml, in 150mM sodium
phosphate (pH 8.5), on CodeLinkTM slides (Amersham
BioSciences, Roosendaal, the Netherlands), using a Spot
Array 72 robot (Perkin Elmer Life Sciences, Zaventum,
Belgium), and processed according to the manufacturer’s
protocol.
Oligoarray preparation
A collection of 18 861 oligo sequences, representing 18 664
unique genes (Sigma-Genosys, Zwijndrecht, the Netherlands),
was spotted at a concentration of 10mM, in 150mM sodium
phosphate (pH 8.5), on CodeLinkTM slides (Amersham
BioSciences), using a Spot Array 72 robot (Perkin Elmer
Life Sciences), and processed according to the manufacturer’s
protocol.
Hybridisation procedure
Genomic DNA was isolated from normal kidney (female
donor), blood (male donor), or liver (female donor) as a
reference, and from the breast cancer cell line BT474,
according to Snijders et al.7 The DNA from the GM00143 cell
line (Coriell Institute for Medical Research, Camden, New
Jersey, USA) was provided by the Albertson laboratory
(University of California, San Francisco, USA). For the BAC
arrays, DNA labelling and hybridisation were performed
according to Snijders et al,7 using ProbeQuantTM G50
microcolumns (Amersham Biosciences). For the oligoarray
hybridisations, the concentration of formamide was
decreased to 34% and washes were performed at 36 C˚ to
compensate for the reduced target length. Before scanning
slides (Scan Array Express; Perkin Elmer Life Sciences) both
oligoarrays and BAC arrays were dried by centrifugation
(1416g), omitting DAPI staining. Spots were quantified by
Imagene 5.5.4 software (Biodiscovery Ltd, Marina del Rey,
California, USA), using the default settings. Subtraction of
local background was done for the signal mean intensities
in both test and reference DNA channels. Normalisation in
the calculated ratios was done against the average of all
ratios. On the BAC arrays, because the clones were spotted in
triplicate, average and standard deviations were calculated
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for each clone. On the oligoarrays, each experiment was
performed three times and data were taken from one
representative experiment. Average and standard deviations
of log2 ratios were calculated for each oligonucleotide across
the three experiments. A moving average (window of eight
by eight) was applied to plot genome wide graphs.
RESULTS AND DISCUSSION
We hybridised a 19 K human 60 mer oligoarray with breast
tumour cell line (BT474) DNA, labelled with Cy3, and normal
genomic kidney (female) DNA, labelled with Cy5. Ratios for
the non-flagged oligos (35%) were ordered by their position
on the chromosome (June 2002 freeze; http://genome.ucsc.
edu/). We compared the oligo CGH profile with the BAC array
CGH profile (fig 1). Both array profiles showed the same
pattern—for example, on the short arm of chromosome 1
neither profile showed a change in DNA copy number,
whereas on the q arm two amplified areas are present in both
profiles. No aberrations can be seen on chromosome 2. The
standard deviation of the log2 ratio of the individual probes
was 0.21 for the BAC array and 0.45 for the oligoarray. On
chromosome 3, a loss on the short arm was evident on the
oligoarray, and was also seen with the BAC array (fig 1).
Figure 2 shows two regions of amplification on the q arm of
chromosome 17: one narrow peak over the chromosomal
region containing c-Erb-B2/neu (Her2)10 and a second
amplicon distal to c-Erb-b2. The BAC array has three clones
over c-Erb-B2, and the best possible judgment towards the
start and end of the amplicon, according to the April 2003
freeze, is therefore 2.5 Mb. With the oligo approach, 38
non-flagged oligos represent amplified ratios in this region
and the size of the amplicon is 2.4 Mb according to the April
2003 freeze. Thus, the actual resolution in the region is 63 kb
on average. The log2 ratios for the three replicate BACs
containing the c-Erb-b2 gene are 2.91, 3.06, and 2.53, a
similar order of magnitude as that obtained in three
independent experiments with the oligoarray for the single
oligo corresponding to the c-Erb-b2 gene: 3.4, 3.4, and 3.9.
Figure 1 Microarray comparative
genomic hybridisation (CGH) profile of
the BT474 cell line. (A) Bacterial/phage
artificial chromosome polymerase chain
reaction representations were used as
probe DNAs spotted on to the glass
slide; (B) oligonucleotides were used as
probe DNAs spotted on to the glass
slide. Moving average applied to the
log2 ratio of the oligo CGH profile. The
vertical bars indicate the spacing
between the chromosomes.
Figure 2 Microarray comparative
genomic hybridisation (CGH) profile of
the long arm of chromosome 17 of the
BT474 cell line. Grey triangles,
bacterial/phage artificial chromosome
polymerase chain reaction
representations were used as probe
DNAs spotted on to the glass slide;
black squares, oligonucleotides were
used as probe DNAs spotted on to the
glass slide (log2 ratio without moving
average). The horizontal bars indicate
the two separate amplicons observed.
Figure 3 Microarray comparative
genomic hybridisation profile of the
GM00143 cell line with a trisomy of
chromosome 18. Moving average
applied to the log2 ratio. The vertical
bars indicate spacing between the
chromosomes.
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The same observation can be made for the second amplicon
on chromosome 17q.
The numbers for the comparison of those specific arrays
not withstanding, it is obvious that an almost infinite
amount of oligos can be rapidly synthesised for a specific
region of interest, whereas the BACs are limited, especially by
size, but also because availability and processing of the BACs
is slower than for oligos.
As a further test of whether the oligo CGH is sensitive
enough to detect single copy number changes, we performed
a hybridisation with DNA from cell line GM0143 (female
donor), which has trisomy of chromosome 18, and normal
liver DNA (female donor). The theoretical ratio of a trisomy
should be 1.5 (log2 ratio, 0.58) and the BAC array showed a
log2 ratio value of 0.49 (SD, 0.05).
7 For the oligoarray
the average of the log2 ratio was 0.31 (SD, 0.49) (fig 3).
Although this single gain can be clearly distinguished by
using a moving average (eight by eight), the high standard
deviation indicates the need to optimise the hybridisation
conditions.
‘‘An almost infinite amount of oligos can be rapidly
synthesised for a specific region of interest, whereas the
bacterial artificial chromosomes are limited, especially by
size’’
In this first set of experiments, the percentage of spots that
were flagged was very high (65%). These non-hybridising
oligos could be partially explained by the fact that some
oligos span exon–exon boundaries. Therefore, a dedicated
oligo library specifically designed for array CGH, analogous to
the situation with expression microarrays, could improve the
performance of oligo CGH even further.
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Take home message
N We describe pilot experiments that serve as a proof of
principle that oligonucleotides are a feasible platform
for array comparative genomic hybridisation (CGH)
N Oligoarray CGH can be rapidly, cost effectively, and
easily used to measure chromosomal copy number
changes for any organism with a fully sequenced
genome
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